{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:19:56Z","timestamp":1787030396746,"version":"build-2736575974"},"reference-count":58,"publisher":"China Science Publishing & Media Ltd.","issue":"7","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.3724\/abbs.2024077","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T03:10:13Z","timestamp":1717470613000},"page":"1055-1064","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["EZH2 inhibition induces senescence via ERK1\/2 signaling pathway in multiple myeloma"],"prefix":"10.3724","volume":"56","author":[{"given":"Shushan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaikang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"L\u00f3pez-Ot\u00edn C","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab, 2023, 35: 12-35.","journal-title":"Cell Metab"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","volume":"15","author":"Mu\u00f1oz-Esp\u00edn D","year":"2014","unstructured":"Mu\u00f1oz-Esp\u00edn D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol, 2014, 15: 482-496.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"Herranz N","year":"2018","unstructured":"Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest, 2018, 128: 1238-1246.","journal-title":"J Clin Invest"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"107817","DOI":"10.1016\/j.pharmthera.2021.107817","volume":"223","author":"Hu D","year":"2021","unstructured":"Hu D, Yuan S, Zhong J, Liu Z, Wang Y, Liu L, Li J. Cellular senescence and hematological malignancies: from pathogenesis to therapeutics. Pharmacol Ther, 2021, 223:","journal-title":"Pharmacol Ther"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"e59756","DOI":"10.1371\/journal.pone.0059756","volume":"8","author":"Andr\u00e9 T","year":"2013","unstructured":"Andr\u00e9 T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L. Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS One, 2013, 8:","journal-title":"PLoS One"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41419-018-0545-6","volume":"9","author":"Guo J","year":"2018","unstructured":"Guo J, Zhao Y, Fei C, Zhao S, Zheng Q, Su J, Wu D. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death Dis, 2018, 9:","journal-title":"Cell Death Dis"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"35533","DOI":"10.1038\/srep35533","volume":"6","author":"Wang LX","year":"2016","unstructured":"Wang LX, Wang JD, Chen JJ, Long B, Liu LL, Tu XX, Luo Y. Aurora a kinase inhibitor AKI603 induces cellular senescence in chronic myeloid leukemia cells harboring T315I mutation. Sci Rep, 2016, 6:","journal-title":"Sci Rep"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/emboj.2011.492","volume":"31","author":"Barascu A","year":"2012","unstructured":"Barascu A, Le Chalony C, Pennarun G, Genet D, Imam N, Lopez B, Bertrand P. Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J, 2012, 31: 1080-1094.","journal-title":"EMBO J"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00018-020-03638-0","volume":"78","author":"Rattanavirotkul N","year":"2021","unstructured":"Rattanavirotkul N, Kirschner K, Chandra T. Induction and transmission of oncogene-induced senescence. Cell Mol Life Sci, 2021, 78: 843-852.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/aps.2017.198","volume":"39","author":"Liu X","year":"2018","unstructured":"Liu X, Ding J, Meng L. Oncogene-induced senescence: a double edged sword in cancer. Acta Pharmacol Sin, 2018, 39: 1553-1558.","journal-title":"Acta Pharmacol Sin"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"Hernandez-Segura A","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol, 2018, 28: 436-453.","journal-title":"Trends Cell Biol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.10.005","volume":"183","author":"Birch J","year":"2018","unstructured":"Birch J, Barnes PJ, Passos JF. Mitochondria, telomeres and cell senescence: implications for lung ageing and disease. Pharmacol Ther, 2018, 183: 34-49.","journal-title":"Pharmacol Ther"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"Victorelli S","year":"2023","unstructured":"Victorelli S, Salmonowicz H, Chapman J, Martini H, Vizioli MG, Riley JS, Cloix C. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature, 2023, 622: 627-636.","journal-title":"Nature"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0968-0004(00)01609-1","volume":"25","author":"Frey TG","year":"2000","unstructured":"Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci, 2000, 25: 319-324.","journal-title":"Trends Biochem Sci"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"15301","DOI":"10.1073\/pnas.1305462110","volume":"110","author":"Daum B","year":"2013","unstructured":"Daum B, Walter A, Horst A, Osiewacz HD, K\u00fchlbrandt W. Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria. Proc Natl Acad Sci USA, 2013, 110: 15301-15306.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","volume":"200","author":"Guo M","year":"2018","unstructured":"Guo M, Price MJ, Patterson DG, Barwick BG, Haines RR, Kania AK, Bradley JE. EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production. J Immunol, 2018, 200: 1039-1052.","journal-title":"J Immunol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"e1004566","DOI":"10.1371\/journal.pgen.1004566","volume":"10","author":"Popovic R","year":"2014","unstructured":"Popovic R, Martinez-Garcia E, Giannopoulou EG, Zhang Q, Zhang Q, Ezponda T, Shah MY. Histone methyltransferase MMSET\/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet, 2014, 10:","journal-title":"PLoS Genet"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/1541-7786.MCR-16-0242-T","volume":"15","author":"Adamik J","year":"2017","unstructured":"Adamik J, Jin S, Sun Q, Zhang P, Weiss KR, Anderson JL, Silbermann R. EZH2 or HDAC1 inhibition reverses multiple myeloma\u2013induced epigenetic suppression of osteoblast differentiation. Mol Cancer Res, 2017, 15: 405-417.","journal-title":"Mol Cancer Res"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"Duan R","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol, 2020, 13:","journal-title":"J Hematol Oncol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/abbs\/gmy050","volume":"50","author":"Wu Q","year":"2018","unstructured":"Wu Q, Chen Z, Zhang G, Zhou W, Peng Y, Liu R, Chen C. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer. Acta Biochim Biophys Sin, 2018, 50: 693-700.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41375-023-01925-w","volume":"37","author":"Xu L","year":"2023","unstructured":"Xu L, Wang Y, Wang G, Guo S, Yu D, Feng Q, Hu K. Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma. Leukemia, 2023, 37: 1576-1579.","journal-title":"Leukemia"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/leu.2013.288","volume":"28","author":"Lund K","year":"2014","unstructured":"Lund K, Adams PD, Copland M. EZH2 in normal and malignant hematopoiesis. Leukemia, 2014, 28: 44-49.","journal-title":"Leukemia"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13578-020-00505-0","volume":"10","author":"Li Z","year":"2020","unstructured":"Li Z, Li M, Wang D, Hou P, Chen X, Chu S, Chai D. Post-translational modifications of EZH2 in cancer. Cell Biosci, 2020, 10:","journal-title":"Cell Biosci"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ncb2139","volume":"13","author":"Wei Y","year":"2011","unstructured":"Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, Yang CC. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol, 2011, 13: 87-94.","journal-title":"Nat Cell Biol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40364-018-0148-5","volume":"6","author":"Tremblay-LeMay R","year":"2018","unstructured":"Tremblay-LeMay R, Rastgoo N, Pourabdollah M, Chang H. EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies. Biomark Res, 2018, 6:","journal-title":"Biomark Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s43018-023-00553-8","volume":"4","author":"Chibaya L","year":"2023","unstructured":"Chibaya L, Murphy KC, DeMarco KD, Gopalan S, Liu H, Parikh CN, Lopez-Diaz Y. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat Cancer, 2023, 4: 872-892.","journal-title":"Nat Cancer"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/biomedicines10081937","volume":"10","author":"Chuang HH","year":"2022","unstructured":"Chuang HH, Huang MS, Zhen YY, Chuang CH, Lee YR, Hsiao M, Yang CJ. FAK executes anti-senescence via regulating EZH2 signaling in non-small cell lung cancer cells. Biomedicines, 2022, 10:","journal-title":"Biomedicines"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/thno.29520","volume":"9","author":"Yu Y","year":"2019","unstructured":"Yu Y, Qi J, Xiong J, Jiang L, Cui D, He J, Chen P. Epigenetic co-deregulation of EZH2\/TET1 is a senescence-countering, actionable vulnerability in triple-negative breast cancer. Theranostics, 2019, 9: 761-777.","journal-title":"Theranostics"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/15384047.2016.1167291","volume":"17","author":"Mahmoud F","year":"2016","unstructured":"Mahmoud F, Shields B, Makhoul I, Hutchins LF, Shalin SC, Tackett AJ. Role of EZH2 histone methyltrasferase in melanoma progression and metastasis. Cancer Biol Ther, 2016, 17: 579-591.","journal-title":"Cancer Biol Ther"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","volume":"9","author":"Fan T","year":"2011","unstructured":"Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CCR, Hornyak TJ. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression. Mol Cancer Res, 2011, 9: 418-429.","journal-title":"Mol Cancer Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"110996","DOI":"10.1016\/j.biopha.2020.110996","volume":"133","author":"Zhan Y","year":"2021","unstructured":"Zhan Y, Jiang L, Jin X, Ying S, Wu Z, Wang L, Yu W. Inhibiting RRM2 to enhance the anticancer activity of chemotherapy. Biomed Pharmacother, 2021, 133:","journal-title":"Biomed Pharmacother"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12032-022-01715-x","volume":"39","author":"Liu Q","year":"2022","unstructured":"Liu Q, Song C, Li J, Liu M, Fu L, Jiang J, Zeng Z. E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2. Med Oncol, 2022, 39:","journal-title":"Med Oncol"},{"key":"CITATION33","unstructured":"Grolmusz VK, Kar\u00e1szi K, Micsik T, T\u00f3th EA, M\u00e9sz\u00e1ros K, Karvaly G, Barna G,                          et al. Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.                                                       Am J Cancer Res                          2016, 6: 2041\u20132053."},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.18632\/aging.204315","volume":"14","author":"Wu L","year":"2022","unstructured":"Wu L, Yin L, Ma L, Yang J, Yang F, Sun B, Nianzeng X. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2 (RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer. Aging, 2022, 14: 7890-7905.","journal-title":"Aging"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"10947","DOI":"10.1093\/nar\/gkac885","volume":"50","author":"Song Q","year":"2022","unstructured":"Song Q, Hou Y, Zhang Y, Liu J, Wang Y, Fu J, Zhang C. Integrated multi-omics approach revealed cellular senescence landscape. Nucleic Acids Res, 2022, 50: 10947-10963.","journal-title":"Nucleic Acids Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1101\/gad.179515.111","volume":"25","author":"Shimi T","year":"2011","unstructured":"Shimi T, Butin-Israeli V, Adam SA, Hamanaka RB, Goldman AE, Lucas CA, Shumaker DK. The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev, 2011, 25: 2579-2593.","journal-title":"Genes Dev"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"102257","DOI":"10.1016\/j.ceb.2023.102257","volume":"85","author":"Kim Y","year":"2023","unstructured":"Kim Y. The impact of altered lamin B1 levels on nuclear lamina structure and function in aging and human diseases. Curr Opin Cell Biol, 2023, 85:","journal-title":"Curr Opin Cell Biol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1091\/mbc.e11-10-0884","volume":"23","author":"Freund A","year":"2012","unstructured":"Freund A, Laberge RM, Demaria M, Campisi J, Magin TM. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell, 2012, 23: 2066-2075.","journal-title":"Mol Biol Cell"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1101\/gad.217281.113","volume":"27","author":"Sadaie M","year":"2013","unstructured":"Sadaie M, Salama R, Carroll T, Tomimatsu K, Chandra T, Young ARJ, Narita M. Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence. Genes Dev, 2013, 27: 1800-1808.","journal-title":"Genes Dev"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3892\/mmr.2018.9712","volume":"19","author":"Zou J","year":"2019","unstructured":"Zou J, Lei T, Guo P, Yu J, Xu Q, Luo Y, Ke R. Mechanisms shaping the role of ERK1\/2 in cellular sene scence. Mol Med Report, 2019, 19: 759-770.","journal-title":"Mol Med Report"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.14336\/AD.2023.0621","volume":"15","author":"Sun R","year":"2024","unstructured":"Sun R, Feng J, Wang J. Underlying mechanisms and treatment of cellular senescence-induced biological barrier interruption and related diseases. Aging Dis, 2024, 15:","journal-title":"Aging Dis"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jdermsci.2022.01.002","volume":"105","author":"Hou X","year":"2022","unstructured":"Hou X, Shi J, Sun L, Song L, Zhao W, Xiong X, Lu Y. The involvement of ERK1\/2 and p38 MAPK in the premature senescence of melanocytes induced by H                         2O                         2 through a p53-independent p21 pathway. J Dermatological Sci, 2022, 105: 88-97.","journal-title":"J Dermatological Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"Wang L","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer, 2022, 22: 340-355.","journal-title":"Nat Rev Cancer"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3324\/haematol.2023.282789","volume":"109","author":"Chen G","year":"2024","unstructured":"Chen G, Gao X, Jia X, Wang Y, Xu L, Yu D, Chang S. Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma. Haematologica, 2024, 109: 1206-1219.","journal-title":"Haematologica"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"109771","DOI":"10.1016\/j.abb.2023.109771","volume":"747","author":"Guo S","year":"2023","unstructured":"Guo S, Xu Z, Feng Q, Zhang H, Yu D, Li B, Hu K. Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma. Arch Biochem Biophys, 2023, 747:","journal-title":"Arch Biochem Biophys"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.devcel.2004.10.019","volume":"8","author":"Zhang R","year":"2005","unstructured":"Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP. Formation of macroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell, 2005, 8: 19-30.","journal-title":"Dev Cell"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.ceb.2023.102206","volume":"83","author":"Olan I","year":"2023","unstructured":"Olan I, Handa T, Narita M. Beyond SAHF: an integrative view of chromatin compartmentalization during senescence. Curr Opin Cell Biol, 2023, 83:","journal-title":"Curr Opin Cell Biol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Sun Y","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduction, 2015, 35: 600-604.","journal-title":"J Recept Signal Transduction"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"20685","DOI":"10.1074\/jbc.M908723199","volume":"275","author":"Kim K","year":"2000","unstructured":"Kim K, Nose K, Shibanuma M. Significance of nuclear relocalization of ERK1\/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts. J Biol Chem, 2000, 275: 20685-20692.","journal-title":"J Biol Chem"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/sj.onc.1207467","volume":"23","author":"Todd DE","year":"2004","unstructured":"Todd DE, Densham RM, Molton SA, Balmanno K, Newson C, Weston CR, Garner AP. ERK1\/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene, 2004, 23: 3284-3295.","journal-title":"Oncogene"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"19010","DOI":"10.1002\/jcp.28540","volume":"234","author":"Ning S","year":"2019","unstructured":"Ning S, Ma X. Dephosphorylation\u2010induced EZH2 activation mediated RECK downregulation by ERK1\/2 signaling. J Cell Physiol, 2019, 234: 19010-19018.","journal-title":"J Cell Physiol"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-019-0814-6","volume":"12","author":"Li B","year":"2019","unstructured":"Li B, Chng WJ. EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications. J Hematol Oncol, 2019, 12:","journal-title":"J Hematol Oncol"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.3390\/ijms231911393","volume":"23","author":"Yang C","year":"2022","unstructured":"Yang C, Gu Y, Ge Z, Song C. Targeting EZH2 promotes chemosensitivity of BCL-2 inhibitor through suppressing PI3K and c-KIT signaling in acute myeloid leukemia. Int J Mol Sci, 2022, 23:","journal-title":"Int J Mol Sci"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"Sherr CJ","year":"1996","unstructured":"Sherr CJ. Cancer cell cycles. Science, 1996, 274: 1672-1677.","journal-title":"Science"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbabio.2015.05.017","volume":"1847","author":"Correia-Melo C","year":"2015","unstructured":"Correia-Melo C, Passos JF. Mitochondria: are they causal players in cellular senescence?. Biochim Biophys Acta (BBA)-Bioenergetics, 2015, 1847: 1373-1379.","journal-title":"Biochim Biophys Acta (BBA)-Bioenergetics"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","volume":"23","author":"Wiley CD","year":"2016","unstructured":"Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab, 2016, 23: 303-314.","journal-title":"Cell Metab"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/MCB.01868-08","volume":"29","author":"Moiseeva O","year":"2009","unstructured":"Moiseeva O, Bourdeau V, Roux A, Desch\u00eanes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol, 2009, 29: 4495-4507.","journal-title":"Mol Cell Biol"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/abbs\/gmq130","volume":"43","author":"Cheng H","year":"2011","unstructured":"Cheng H, Qiu L, Zhang H, Cheng M, Li W, Zhao X, Liu K. Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells. Acta Biochim Biophys Sin, 2011, 43: 204-209.","journal-title":"Acta Biochim Biophys Sin"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/B7032B19425B489ABA4350219C534161","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024077","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/B7032B19425B489ABA4350219C534161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:44:53Z","timestamp":1721796293000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,5,27]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024077","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}